Skip to main content
OpenTrials
Completed

NCT Number: NCT05018741

Prognostic Factors After Liver Transplantation

The study retrospectively reviewed the medical records of patients who received adult liver transplantation in Changhua Christian hospital from 2002 to 2019. We collected their personal data about liver disease, laboratory data about liver function, pre-transplant evaluation and post-transplant outcome. We investigate what prognostic factors may contribute a good survival outcome, and improve our clinical practice.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients who received adult liver transplantation in Changhua Christian hospital from 2002 to 2019

Exclusion criteria

  • patients who did not have suitable donor for liver transplantation

Treatment and study plan

Liver Transplantation

Procedure

liver transplantation for chronic liver disease or acute liver failure

Primary outcomes

  1. number of participants with morbidity and mortality after surgery

    Time frame: upto one month after surgery

    post-operative complications which requiring interventions, related to organ failure and hospital mortality

Secondary outcomes

  1. long-term survival rate

    Time frame: upto 5 years after surgery

    1,5 year survival rate

Sponsors and collaborators

Lead sponsor

Changhua Christian Hospital

Other

Registry information

Important dates

Study start
2002
Primary completion
2019
Study completion
2019
First posted
Aug 24, 2021
Registry last updated
Aug 24, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.